Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 9 of 9 entries
View as:

Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)

Phase: N/A Priority: Normal
NCT ID: NCT05322941 Org: User:
Start: 05/06/22 End: 07/22/24 Due: 07/22/25

Phase 1/2 Trial of AEF0217 in Participants With Down Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05748405 Org: User:
Start: 12/15/22 End: 10/07/24 Due: 10/07/25

Study of [4-14C] AEF0117 Following a Single Oral Dose in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05554926 Org: User:
Start: 12/16/22 End: 02/24/23 Due: 02/24/24

Multiple Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117

Phase: N/A Priority: Normal
NCT ID: NCT03443895 Org: User:
Start: 01/08/18 End: 05/01/18 Due: 05/01/19

AEF0217 First-in-Human Phase I Study in 3 Parts (Single and Multiple Ascending Doses, and Food Effect) in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT05170737 Org: User:
Start: 10/01/21 End: 06/28/22 Due: 06/28/23

Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03717272 Org: User:
Start: 10/23/18 End: 01/01/21 Due: 01/01/22

The Effect of Food on the Oral Bioavailability of AEF0117 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05451017 Org: User:
Start: 01/04/23 End: 06/28/23 Due: 06/28/24

Single Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117

Phase: N/A Priority: Normal
NCT ID: NCT03325595 Org: User:
Start: 04/06/17 End: 02/26/18 Due: 02/26/19

Drug-Drug Interaction Between THC and AEF0117

Phase: N/A Priority: Normal
NCT ID: NCT06395688 Org: User:
Start: 02/28/25 End: 06/30/25 Due: 06/30/26